Literature DB >> 8521813

Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation.

J E Damen1, H Wakao, A Miyajima, J Krosl, R K Humphries, R L Cutler, G Krystal.   

Abstract

While previous studies with truncated erythropoietin receptors (EpRs) have suggested that the tyrosine phosphorylation of the EpR does not play a role in Ep-induced proliferation, we have found, using a more subtle, full length EpR mutant, designated Null, in which all eight of the intracellular tyrosines have been substituted with phenylalanine residues, that Null cells require substantially more Ep than wild-type cells in order to proliferate as efficiently. A comparison of Ep-induced proliferation with Ep-induced tyrosine phosphorylation patterns, using wild-type and Null EpR-expressing cells, revealed that Stat5 tyrosine phosphorylation and activation correlated directly with proliferation. Moreover, studies with a Y343F EpR point mutant and various EpR deletion mutants revealed that both Ep-induced proliferation and Stat5 activation were mediated primarily through Y343, but that other tyrosines within the EpR could activate Stat5 in its absence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521813      PMCID: PMC394670          DOI: 10.1002/j.1460-2075.1995.tb00243.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Signal transduction. Just another signalling pathway.

Authors:  J Briscoe; D Guschin; M Müller
Journal:  Curr Biol       Date:  1994-11-01       Impact factor: 10.834

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  A specific in vitro bioassay for measuring erythropoietin levels in human serum and plasma.

Authors:  A W Wognum; V Lam; R Goudsmit; G Krystal
Journal:  Blood       Date:  1990-10-01       Impact factor: 22.113

5.  Expression cloning of the murine erythropoietin receptor.

Authors:  A D D'Andrea; H F Lodish; G G Wong
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

6.  Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.

Authors:  K Sawada; S B Krantz; C H Dai; S T Koury; S T Horn; A D Glick; C I Civin
Journal:  J Cell Physiol       Date:  1990-02       Impact factor: 6.384

7.  Detection and isolation of the erythropoietin receptor using biotinylated erythropoietin.

Authors:  A W Wognum; P M Lansdorp; R K Humphries; G Krystal
Journal:  Blood       Date:  1990-08-15       Impact factor: 22.113

Review 8.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells.

Authors:  F W Quelle; D M Wojchowski
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

10.  Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor.

Authors:  T Sasaoka; D W Rose; B H Jhun; A R Saltiel; B Draznin; J M Olefsky
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

View more
  59 in total

1.  Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.

Authors:  K Nishigaki; C Hanson; T Ohashi; D Thompson; K Muszynski; S Ruscetti
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

3.  The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Authors:  Mojib Javadi; Edda Hofstätter; Natalie Stickle; Bryan K Beattie; Robert Jaster; Christin Carter-Su; Dwayne L Barber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 4.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

5.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 6.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

7.  ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling.

Authors:  Andrew D Wood; Edwin Chen; Ian J Donaldson; Shilpa Hattangadi; Karly A Burke; Mark A Dawson; Diego Miranda-Saavedra; Harvey F Lodish; Anthony R Green; Berthold Göttgens
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

8.  Inactivation of G-protein-coupled receptor 48 (Gpr48/Lgr4) impairs definitive erythropoiesis at midgestation through down-regulation of the ATF4 signaling pathway.

Authors:  Huiping Song; Jian Luo; Weijia Luo; Jinsheng Weng; Zhiqiang Wang; Baoxing Li; Dali Li; Mingyao Liu
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

9.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

Authors:  R Moriggl; V Gouilleux-Gruart; R Jähne; S Berchtold; C Gartmann; X Liu; L Hennighausen; A Sotiropoulos; B Groner; F Gouilleux
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex.

Authors:  Yingxin L Zhang; Mala L Radhakrishnan; Xiaohui Lu; Alec W Gross; Bruce Tidor; Harvey F Lodish
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.